NextPlat (NXPL) Interest & Investment Income (2019 - 2025)
NextPlat's (NXPL) quarterly Interest & Investment Income came in at $63000.0 in Q4 2025, down 53.33% year-over-year from $135000.0 in Q4 2024, and down 28.41% quarter-over-quarter from $88000.0 in Q3 2025.
Powered by 
Analysis
NextPlat (NXPL) Interest & Investment Income (2019 - 2025) Analysis & Trends
NextPlat (NXPL) has reported Interest & Investment Income for 7 consecutive years, with $63000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Interest & Investment Income fell 53.33% year-over-year to $63000.0 in Q4 2025; TTM through Dec 2025 was $358000.0, a 50.96% decrease from a year earlier, with the FY2025 full-year figure at $358000.0, down 51.03% from the prior year.
- Interest & Investment Income was $63000.0 for Q4 2025 at NextPlat, down from $88000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $227000.0 in Q4 2023 and troughed at $3146.0 in Q3 2021.
- A 5-year average of $96437.6 and a median of $93500.0 in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 10557.14% in 2021 and plunged 53.33% in 2025, its largest moves.
- Over 5 years, Interest & Investment Income stood at $3730.0 in 2021, then soared by 103.19% to $7579.0 in 2022, then surged by 2895.12% to $227000.0 in 2023, then plunged by 40.53% to $135000.0 in 2024, then sank by 53.33% to $63000.0 in 2025.
- The last three Interest & Investment Income figures came in at $63000.0 (Q4 2025), $88000.0 (Q3 2025), and $99000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 31.57 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -55.04 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 11.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | -3.64 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -16.41 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 2.29 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 287,000.00 |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 88,000.00 |
| Jun 30, 2025 | 99,000.00 |
| Mar 31, 2025 | 108,000.00 |
| Dec 31, 2024 | 135,000.00 |
| Sep 30, 2024 | 183,000.00 |
| Jun 30, 2024 | 197,000.00 |
| Mar 31, 2024 | 215,000.00 |
| Dec 31, 2023 | 227,000.00 |
| Sep 30, 2023 | 210,000.00 |
| Jun 30, 2023 | 173,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 7,579.00 |
| Sep 30, 2022 | 3,849.00 |
| Jun 30, 2022 | 4,616.00 |
| Mar 31, 2022 | 4,956.00 |
| Dec 31, 2021 | 3,730.00 |
| Sep 30, 2021 | 3,146.00 |
| Dec 31, 2020 | 35.00 |
| Sep 30, 2020 | 67.00 |